Abstract
Objective To quantify brain health using a measure of reserve that incorporates pre-existing pathology.
Methods We analyzed two retrospective ischemic stroke cohorts (GASROS and SALVO) with neuroimaging and 90-day modified Rankin Scores (mRS) available. White matter hyperintensity (WMHv), brain, and intracranial volumes were automatically extracted, and brain parenchymal fraction (BPF) calculated. The latent variable effective reserve (eR) was modeled using age, WMHv, and BPF or brain volume in GASROS. Models were compared using Bayes Information Criterion (BIC). The best model’s eR estimates were categorized into quartiles and evaluated in SALVO.
Results GASROS included 476 (median age: 65.8; 65.3% male) and SALVO included 43 (median age: 69.2; 62.8% male) patients. Inverse associations between eR and mRS was seen in both models, with brain volume outperforming BPF (path coefficients: -0.67, -0.48, respectively; p < 0.001; |ΔBIC| = 362). Quartile-based eR stratification in SALVO showed a similar inverse trend, with worse outcomes in the low reserve group (mRS≤2 - highest vs lowest quartile: 85/90% vs 59/45% for GASROS/SALVO).
Conclusions Expanding the concept of eR, highlights its clinical translational potential. The strong link between higher eR and better outcomes underscores its value as a protective brain health metric.
- brain health
- effective reserve
- brain reserve
- stroke
- outcome
Competing Interest Statement
Research reported in this publication was supported by the National Institute of Aging of the National Institutes of Health under award number R21AG083559. NSR is supported by NINDS U19NS115388. RWR serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Microvention and Penumbra, and receives research grant support from National Institutes of Health (NINDS R25NS065743), Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. MDS is supported by the Heinz Family Foundation, Heitman Stroke Foundation, and NIA R21AG083559.
Funding Statement
Research reported in this publication was supported by the National Institute of Aging of the National Institutes of Health under award number R21AG083559. NSR is supported by NINDS U19NS115388. RWR serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Microvention and Penumbra, and receives research grant support from National Institutes of Health (NINDS R25NS065743), Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. MDS is supported by the Heinz Family Foundation, Heitman Stroke Foundation, and NIA R21AG083559.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Massachusetts General Brigham gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Format has been changed, secondary cohort was included, and clinical utility was further highlighted.
Data Availability
The authors agree to make the data, methods used in the analysis, and materials used to conduct the research available to any researcher for the express purpose of reproducing the results and with the explicit permission for data sharing by the local institutional review board.
